Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · The Lancet Oncology · 2006
Cited by 1,573 works. doi:10.1016/s1470-2045(06)70804-x
Authors
- Jean‐Yves Douillard
- Rafael Rosell
- Mario De Lena
- Francesco Carpagnano
- Rodryg Ramlau
- J.L. González-Larriba
- Tomasz Grodzki
- José Rodrigues Pereira
- Alain Le Groumellec
- Vito Lorusso
- C. Clary
- Antonio Jose Torres
- Jabrail Dahabreh
- Pierre-Jean Souquet
- Julio Astudillo
- P. Fournel
- Angel Artal
- Jacek Jassem
- Leona Koubková
- Patricia His
References
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
- Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
- Estimating the world cancer burden: Globocan 2000
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
- A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer
- Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
- Ten-year survey of lung cancer treatment and survival in hospitals in the United States
- Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633